Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting ...

This should lead to increased levels of LCA at birth. LCA, cholic acid (CA) and chenodeoxycholic acid (CDCA) were quantitated in stored dried blood from six newborn infants with EHBA and fourteen ...

For the first time, researchers demonstrate that intermittent fasting can reduce hypertension by reshaping the gut microbiota ...

Post gallbladder removal surgery, your body might struggle with fat digestion, resulting in problems like discomfort, bloating, and various other digestive issues. A potential remedy for this ...

As well as having a role in lipid absorption, bile acids can act as endocrine-signaling molecules. With previous studies suggesting that bile acids operate as metabolic integrators, Watanabe et al.

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting ...

Mirum has three approved medications: LIVMARLI® (maralixibat) oral solution, CHOLBAM® (cholic acid) capsules, and CHENODAL® (chenodiol) tablets. LIVMARLI, an IBAT inhibitor, is approved for the ...

Outcomes are compared with 6-month outcomes after anterior 180° partial fundoplication, and sham procedures from trials of endoscopic therapies. No sham-controlled trial of EsophyX TIF procedure ...

Background and Aims: The tests that are currently available for the diagnosis of gastroesophageal reflux disease (GERD) lack the desired diagnostic accuracy. To date, only pH monitoring has been ...

Q3 2024 Earnings Call Transcript October 31, 2024 Travere Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...